Category Archive: Finance

Bull Of The Day: Sturm, Ruger & Company

Bull Of The Day: Sturm, Ruger & Company

Guns remain a hot button issue as the debate rages on over the role of firearms in American society. But one thing can’t really be up for debate anymore, and that is the strength of the gunmaker stocks, and the soaring demand for firearms. Take a look at Sturm, Ruger & Company (RGR – Snapshot Report) as […]
S&P 500 And Nasdaq 100 Forecast – March 14, 2016

S&P 500 And Nasdaq 100 Forecast – March 14, 2016

S&P 500 The S&P 500 broke higher during the course of the day on Friday, breaking the top of the wild candle from Thursday. Because of this, the market looks as if it is ready to go higher and therefore I am bullish of the S&P 500 at the moment. However, there are a lot […]
Don’t Buy The EUR

Don’t Buy The EUR

EUR/USD is off the post-Draghi backfire highs but doesn’t easily fall off the 1.11 handle. The team at Credit Agricole does not like euro shorts: Here is their view, courtesy of eFXnews: Risk sentiment was stable in Asian hours, irrespective of weaker than expected industrial production and retail sales data out of China. It appears that last […]
General Motors Buying Driverless Car Technology For $1 Billion

General Motors Buying Driverless Car Technology For $1 Billion

Written by Kyle Stanford, PitchBook Taking its next step toward the future of cars, General Motors (GM) has announced that it’s acquiring autonomous vehicle startup Cruise Automation for a reported $1 billion in a deal expected to close in 2Q. Once the deal is completed, Cruise will operate as an independent unit within General Motors recently formed […]
E
                                                
                        Catching Up With Warren Buffett

E Catching Up With Warren Buffett

One of my favorite research pieces to read every year is Warren Buffett’s annual letter to the shareholders of Berkshire Hathaway (BRK-A),his gigantic holding company. Not only does it paint an excellent broad-brush picture of the US economy, it is also witty, funny, and downright educational, even for old farts such as myself. Warren and […]
$2,000 Gold & $50 Silver Quite Likely This Year – Here’s Why

$2,000 Gold & $50 Silver Quite Likely This Year – Here’s Why

Written by Egon von Greyerz of Gold Switzerland. Gold is in a hurry and is unlikely to wait for investors to acquire it at anywhere near these prices. We could now see a quick move to $1,400 and if gold doesn’t stay too long at that level, the acceleration is likely to continue towards the previous high […]
Silver Prices Are Slightly Higher

Silver Prices Are Slightly Higher

The short-term trend is bullish above Thursday’s low of $15.16 and as long as this low is respected by traders, silver prices may drift higher. On a breach to Thursday’s low of $15.16, the trend may turn bearish and a decline to the March 3 low of $14.87 may come into play. The bullish trend […]
How To “Pre-Trade” FOMC Days

How To “Pre-Trade” FOMC Days

The biggest movers on FOMC days are the Dollar Index, Investment-grade credit, Homebuilders and Real Estate, according to Goldman Sachs’ options strategists. We analyze the median 1-day moves on FOMC release days across broad based US equity indices, sectors, and country ETFs over the last year, and also back to January 2010, to rank the assets by […]
Get The Scoop On The Top 4 Financial Assets To Trade This Week

Get The Scoop On The Top 4 Financial Assets To Trade This Week

Zhou Xiaochuan Expects Prudent Monetary Policy with Loosening Bias….. In case you’re wondering who Mr Xiaochuan is, he is the Governor of the People’s Bank of China. His opinion is currently as important as that of Mario Draghi of the European Central Bank, or Janet Yellen of the Federal Reserve Bank. While the impact of […]
E
                                                
                        GW Pharmaceuticals Soars On Positive Phase 3 Results

E GW Pharmaceuticals Soars On Positive Phase 3 Results

Today shares of GW Pharmaceuticals plc (GWPH) are up for more than 124% after the company announced positive phase 3 results for a trial using its drug Epidiolex. The drug was able to meet the primary endpoint of the study, reduction of seizures compared to a placebo compound over the course of the entire trial […]